<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the frequency of Acquired Amegakaryocytic Thrombocytopenic <z:hpo ids='HP_0000979'>Purpura</z:hpo> (AATT), possible aetiology, course and prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Retrospectively diagnosed patients, treated and followed prospectively </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: One hundred twenty patients with thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Response to treatment and course of disease </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Out of 22 patients 2 died of cerebral haemorrhage, one transformed to <z:hpo ids='HP_0002863'>Myelodysplastic Syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), one transformed to <z:hpo ids='HP_0011009'>Acute</z:hpo> Myeloid Levkaenia (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>None is transfusion independent </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: AATT is not an infrequent disorder </plain></SENT>
<SENT sid="8" pm="."><plain>It shows poor response to <z:hpo ids='HP_0000001'>all</z:hpo> available therapeutic modalities and has a potential for transformation into <z:hpo ids='HP_0002863'>Myelodysplasia</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
</text></document>